Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT · IEX Real-Time Price · USD
0.540
+0.017 (3.27%)
At close: May 8, 2024, 3:37 PM
0.578
+0.038 (6.96%)
After-hours: May 8, 2024, 6:05 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $14.43 million as of May 8, 2024. Its market cap has decreased by -61.11% in one year.
Market Cap
14.43M
Enterprise Value
-144.93K
1-Year Change
-61.11%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since November 20, 2015, Purple Biotech's market cap has increased from $11.20M to $14.43M, an increase of 28.82%. That is a compound annual growth rate of 3.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 7, 2024 | 10.10M | -2.88% |
May 6, 2024 | 10.40M | -0.95% |
May 3, 2024 | 10.50M | -1.87% |
May 2, 2024 | 10.70M | 2.88% |
May 1, 2024 | 10.40M | 0.97% |
Apr 30, 2024 | 10.30M | 1.98% |
Apr 29, 2024 | 10.10M | 4.12% |
Apr 26, 2024 | 9.70M | -4.90% |
Apr 25, 2024 | 10.20M | - |
Apr 24, 2024 | 10.20M | 5.15% |
Apr 23, 2024 | 9.70M | 7.78% |
Apr 22, 2024 | 9.00M | - |
Apr 19, 2024 | 9.00M | -1.10% |
Apr 18, 2024 | 9.10M | 5.81% |
Apr 17, 2024 | 8.60M | 4.88% |
Apr 16, 2024 | 8.20M | -29.31% |
Apr 15, 2024 | 11.60M | -4.92% |
Apr 12, 2024 | 12.20M | - |
Apr 11, 2024 | 12.20M | -10.29% |
Apr 10, 2024 | 13.60M | -4.23% |
Apr 9, 2024 | 14.20M | - |
Apr 8, 2024 | 14.20M | 2.16% |
Apr 5, 2024 | 13.90M | - |
Apr 4, 2024 | 13.90M | -0.71% |
Apr 3, 2024 | 14.00M | 4.48% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Microbot Medical | 13.72M |
Avalo Therapeutics | 13.70M |
Pieris Pharmaceuticals | 13.65M |
RedHill Biopharma | 13.63M |
Dominari Holdings | 13.41M |
Monopar Therapeutics | 13.30M |
Kiora Pharmaceuticals | 13.15M |
Trinity Biotech | 12.95M |